Engst, Stefan
Exelixis (United States)
2 papers on CoChat
Most cited papers
- Verified
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Qian, F., Engst, S., Yamaguchi, K., Yu, P., Won, K.-A., Mock, L., Lou, T., Tan, J., Li, C., Tam, D., et al. (2009) · Cancer Research
Angiogenesis and VEGF in CancerCancer Mechanisms and Therapy
Cited by 350
- Verified
Intermittent Administration of MEK Inhibitor GDC-0973 plus PI3K Inhibitor GDC-0941 Triggers Robust Apoptosis and Tumor Growth Inhibition
Hoeflich, K. P., Merchant, M., Orr, C., Chan, J., Den Otter, D., Berry, L., Kasman, I., Koeppen, H., Rice, K., Yang, N.-Y., et al. (2012) · Cancer Research
Melanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 242
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free